$2.33T
Total marketcap
$89.68B
Total volume
BTC 50.01%     ETH 15.41%
Dominance

Hyundai Pharmaceutical Co., Ltd. 004310.KS Stock

3765 KRW {{ price }} -0.528402% {{change_pct}}%
Exchange
KSE
Market Cap
100.95B KRW
LOW - HIGH [24H]
3720 - 3765 KRW
VOLUME [24H]
21.79K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

Hyundai Pharmaceutical Co., Ltd. Price Chart

Hyundai Pharmaceutical Co., Ltd. 004310.KS Financial and Trading Overview

Hyundai Pharmaceutical Co., Ltd. stock price 3765 KRW
Previous Close 4180 KRW
Open 4190 KRW
Bid 4200 KRW x 0
Ask 4205 KRW x 0
Day's Range 4150 - 4240 KRW
52 Week Range 3780 - 6940 KRW
Volume 91.7K KRW
Avg. Volume 207.63K KRW
Market Cap 115.78B KRW
Beta (5Y Monthly) 0.860694
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date December 28, 2022
1y Target Est N/A

004310.KS Valuation Measures

Enterprise Value 111.56B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.070679
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.032
Enterprise Value/EBITDA 25.958

Trading Information

Hyundai Pharmaceutical Co., Ltd. Stock Price History

Beta (5Y Monthly) 0.860694
52-Week Change -5.0000012%
S&P500 52-Week Change 20.43%
52 Week High 6940 KRW
52 Week Low 3780 KRW
50-Day Moving Average 4929.1 KRW
200-Day Moving Average 4864.78 KRW

004310.KS Share Statistics

Avg. Volume (3 month) 207.63K KRW
Avg. Daily Volume (10-Days) 234.76K KRW
Shares Outstanding 27.53M
Float 16.84M
Short Ratio N/A
% Held by Insiders 24.38%
% Held by Institutions 1.12%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 10:1

Financial Highlights

Fiscal Year

Fiscal Year Ends November 30, 2013
Most Recent Quarter (mrq) November 30, 2013
Next Fiscal Year End November 30, 2014

Profitability

Profit Margin 1.30%
Operating Margin (ttm) 2.02%
Gross Margin 37.44%
EBITDA Margin 3.97%

Management Effectiveness

Return on Assets (ttm) 0.93%
Return on Equity (ttm) 1.45%

Income Statement

Revenue (ttm) 108.14B KRW
Revenue Per Share (ttm) 4611.46 KRW
Quarterly Revenue Growth (yoy) 5.00%
Gross Profit (ttm) 40.49B KRW
EBITDA 4.3B KRW
Net Income Avi to Common (ttm) 1.41B KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 14.63B KRW
Total Cash Per Share (mrq) 623.91 KRW
Total Debt (mrq) 20.75B KRW
Total Debt/Equity (mrq) 20.5 KRW
Current Ratio (mrq) 2.196
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) 7.95B KRW
Levered Free Cash Flow (ttm) 6.29B KRW

Profile of Hyundai Pharmaceutical Co., Ltd.

Country South Korea
State N/A
City Seoul
Address Hyundai Pharm Building
ZIP 06121
Phone N/A
Website https://www.hyundaipharm.co.kr
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and eye vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. The company was founded in 1965 and is headquartered in Seoul, South Korea.

Q&A For Hyundai Pharmaceutical Co., Ltd. Stock

What is a current 004310.KS stock price?

Hyundai Pharmaceutical Co., Ltd. 004310.KS stock price today per share is 3765 KRW.

How to purchase Hyundai Pharmaceutical Co., Ltd. stock?

You can buy 004310.KS shares on the KSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hyundai Pharmaceutical Co., Ltd.?

The stock symbol or ticker of Hyundai Pharmaceutical Co., Ltd. is 004310.KS.

Which industry does the Hyundai Pharmaceutical Co., Ltd. company belong to?

The Hyundai Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.

How many shares does Hyundai Pharmaceutical Co., Ltd. have in circulation?

The max supply of Hyundai Pharmaceutical Co., Ltd. shares is 26.81M.

What is Hyundai Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?

Hyundai Pharmaceutical Co., Ltd. PE Ratio is now.

What was Hyundai Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?

Hyundai Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.

Which sector does the Hyundai Pharmaceutical Co., Ltd. company belong to?

The Hyundai Pharmaceutical Co., Ltd. sector is Healthcare.